The pathways of carcinogenesis for vaginal cancer can be divided into human papillomavirus (HPV) induced and non-HPV induced.

Historically, diethylstilbestrol (DES), a synthetic estrogen used to prevent miscarriages and preterm labor, has been associated with vaginal clear cell adenocarcinoma in offspring.